Literature DB >> 24528745

Inulin isoforms differ by repeated additions of one crystal unit cell.

Peter D Cooper1, Thomas G Barclay2, Milena Ginic-Markovic2, Andrea R Gerson2, Nikolai Petrovsky3.   

Abstract

Inulin isoforms, especially delta inulin, are important biologically as immune activators and clinically as vaccine adjuvants. In exploring action mechanisms, we previously found regular increments in thermal properties of the seven-member inulin isoform series that suggested regular additions of some energetic structural unit. Because the previous isolates carried additional longer chains that masked defining ranges, these were contrasted with new isoform isolates comprising only inulin chain lengths defining that isoform. The new series began with 19 fructose units per chain (alpha-1 inulin), increasing regularly by 6 fructose units per isoform. Thus the 'energetic unit' equates to 6 fructose residues per chain. All isoforms showed indistinguishable X-ray diffraction patterns that were also identical with known inulin crystals. We conclude that an 'energetic unit' equates to one helix turn of 6 fructose units per chain as found in one unit cell of the inulin crystal. Each isoform chain comprised progressively more helix turns plus one additional fructose and glucose residues per chain.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Carbohydrate; Inulin; Isoform; Polymorph; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 24528745      PMCID: PMC4051881          DOI: 10.1016/j.carbpol.2013.12.066

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  15 in total

1.  THE PHYSICAL PROPERTIES OF INULIN SOLUTIONS.

Authors:  C F PHELPS
Journal:  Biochem J       Date:  1965-04       Impact factor: 3.857

Review 2.  Vaccine adjuvants: current state and future trends.

Authors:  Nikolai Petrovsky; Julio César Aguilar
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

3.  Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.

Authors:  Yoshikazu Honda-Okubo; Fadi Saade; Nikolai Petrovsky
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

4.  Single crystals of inulin.

Authors:  I André; J L Putaux; H Chanzy; F R Taravel; J W Timmermans; D de Wit
Journal:  Int J Biol Macromol       Date:  1996-04       Impact factor: 6.953

5.  Anti-complementary action of polymorphic "solubility forms" of particulate inulin.

Authors:  P D Cooper; M Carter
Journal:  Mol Immunol       Date:  1986-08       Impact factor: 4.407

6.  Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Authors:  David L Gordon; Dimitar Sajkov; Richard J Woodman; Yoshikazu Honda-Okubo; Manon M J Cox; Susanne Heinzel; Nikolai Petrovsky
Journal:  Vaccine       Date:  2012-06-17       Impact factor: 3.641

7.  Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy.

Authors:  Thomas Barclay; Milena Ginic-Markovic; Martin R Johnston; Peter D Cooper; Nikolai Petrovsky
Journal:  Carbohydr Res       Date:  2012-03-10       Impact factor: 2.104

8.  Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Authors:  Peter D Cooper; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2010-12-07       Impact factor: 4.313

9.  Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.

Authors:  P D Cooper; T G Barclay; M Ginic-Markovic; N Petrovsky
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

10.  Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin.

Authors:  M Korbelik; P D Cooper
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

View more
  9 in total

1.  Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.

Authors:  David Gordon; Peter Kelley; Susanne Heinzel; Peter Cooper; Nikolai Petrovsky
Journal:  Vaccine       Date:  2014-09-27       Impact factor: 3.641

2.  Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation.

Authors:  Thomas G Barclay; Harinda Rajapaksha; Alagu Thilagam; Gujie Qian; Milena Ginic-Markovic; Peter D Cooper; Andrea Gerson; Nikolai Petrovsky
Journal:  Carbohydr Polym       Date:  2016-01-29       Impact factor: 9.381

3.  Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: atomic force microscopy and static molecular modelling.

Authors:  Peter D Cooper; K Harinda Rajapaksha; Thomas G Barclay; Milena Ginic-Markovic; Andrea R Gerson; Nikolai Petrovsky
Journal:  Carbohydr Polym       Date:  2014-10-23       Impact factor: 9.381

4.  Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines.

Authors:  Ricardo Calderon-Gonzalez; Raquel Tobes; Eduardo Pareja; Elisabet Frande-Cabanes; Nikolai Petrovsky; Carmen Alvarez-Dominguez
Journal:  J Immunol Methods       Date:  2015-05-29       Impact factor: 2.303

5.  Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation.

Authors:  Lixin Wang; Yunmei Song; Ankit Parikh; Paul Joyce; Rosa Chung; Liang Liu; Franklin Afinjuomo; John D Hayball; Nikolai Petrovsky; Thomas G Barclay; Sanjay Garg
Journal:  Pharmaceutics       Date:  2019-11-06       Impact factor: 6.321

6.  Rheological Characteristics of Soluble Fibres during Chemically Simulated Digestion and their Suitability for Gastroparesis Patients.

Authors:  Harsha Suresh; Vincent Ho; Jerry Zhou
Journal:  Nutrients       Date:  2020-08-17       Impact factor: 5.717

Review 7.  Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Vaccine       Date:  2015-09-25       Impact factor: 3.641

8.  Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.

Authors:  David L Gordon; Dimitar Sajkov; Yoshikazu Honda-Okubo; Samuel H Wilks; Malet Aban; Ian G Barr; Nikolai Petrovsky
Journal:  Vaccine       Date:  2016-06-21       Impact factor: 3.641

9.  Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery.

Authors:  Franklin Afinjuomo; Thomas G Barclay; Ankit Parikh; Rosa Chung; Yunmei Song; Gayathri Nagalingam; Jamie Triccas; Lixin Wang; Liang Liu; John D Hayball; Nikolai Petrovsky; Sanjay Garg
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.